{"title":"Features of myocardial infarction with ST segment elevation in patients with non-alcoholic liver steatosis and steatohepatitis","authors":"V. A. Tretyakova, O. V. Ermilov, P. K. Alferov","doi":"10.32756/0869-5490-2023-4-51-57","DOIUrl":null,"url":null,"abstract":"To evaluate the features of ST-segment elevation myocardial infarction (STEMI) in patients with two types of metabolic-associated fatty liver disease (MAFLD), that is, liver steatosis (LS) and steatohepatitis (SH).","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"13 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical pharmacology and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32756/0869-5490-2023-4-51-57","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
To evaluate the features of ST-segment elevation myocardial infarction (STEMI) in patients with two types of metabolic-associated fatty liver disease (MAFLD), that is, liver steatosis (LS) and steatohepatitis (SH).
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
